Citadel Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Citadel Advisors’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,314	Closed	-$1.04M	–	9284
2014 Q4	$1.04M	Sell	10,314 -121,342	-92%	-$9.43M	﹤0.01%	3724
2014 Q3	$8.73M	Buy	131,656 +59,274	+82%	+$3.89M	0.01%	1473
2014 Q2	$5.05M	Buy	72,382 +37,084	+105%	+$2.52M	0.01%	1827
2014 Q1	$2.58M	Buy	35,298 +4,846	+16%	+$361K	﹤0.01%	2391
2013 Q4	$2.1M	Sell	30,452 -541,202	-95%	-$35M	﹤0.01%	2503
2013 Q3	$36.3M	Buy	571,654 +421,739	+281%	+$25.5M	0.06%	438
2013 Q2	$7.24M	Buy	+149,915	New	+$7.37M	0.01%	1271

Citadel Advisors's CBST Position: Q1 2015 in Review

Citadel Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 10,314 shares — an estimated $1.04M sold.

Citadel Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $36.3M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Citadel Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Citadel Advisors sold 10,314 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.04M.
Citadel Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Citadel Advisors's CUBIST PHARMACEUTICALS INC position peaked at $36.3M in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.